RT Journal Article
SR Electronic
T1 The relationship between social risk factors and latent tuberculosis infection among individuals residing in England: a cross-sectional study
JF BMJ Global Health
JO BMJ Global Health
FD BMJ Publishing Group Ltd
SP e003550
DO 10.1136/bmjgh-2020-003550
VO 5
IS 12
A1 Swaib A Lule
A1 Rishi K Gupta
A1 Maria Krutikov
A1 Charlotte Jackson
A1 Jo Southern
A1 Ibrahim Abubakar
YR 2020
UL http://gh.bmj.com/content/5/12/e003550.abstract
AB Objective To investigate the relationship between social risk factors and latent tuberculosis infection (LTBI) among individuals who are eligible for LTBI screening in the United Kingdom (UK).Methods This cross-sectional study used data collected in the UK Prognostic Evaluation of Diagnostic Interferon-Gamma Release Assays (IGRAs) Consortium Study which enrolled 9176 recent tuberculosis (TB) contacts and migrants at National Health Service (NHS) facilities and community settings in the UK. The study outcome was LTBI (positive IGRA test (QuantiFERON-TB Gold In-Tube or T-SPOT.TB)). The main exposures were history of smoking, history of substance misuse, homelessness, prison stay and socioeconomic deprivation.Results 4914 (56.2%) individuals resided in the most deprived areas and 2536 (27.6%) had LTBI. In the multivariable analysis (adjusting for age, gender, place of birth, ethnicity, HIV status, BCG vaccination and recent TB contact) living in the least deprived areas compared with living in the most deprived areas was associated with reduced odds of LTBI (odds ratio (OR)=0.68, 95% CI: 0.51 to 0.90) while ever been homeless (OR=1.50, 95% CI: 1.02 to 2.21) was associated with increased odds of LTBI. Smoking, homelessness and substance misuse were not associated with LTBI.Conclusion Social deprivation could be an important risk factor for LTBI, highlighting the social inequality in the burden of TB infection in the UK. Migrants and TB contacts who were socially deprived or homeless were at a significantly higher risk for LTBI, thus tailored intense public health interventions to these groups may help to reduce the risk of future TB disease.Trial registration number ClinicalTrials.gov Registry (NCT01162265).